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Background: Current assays for monitoring DNA excision repair in vivo lack sensitivity.
Results: An in vivo excision assay can be used to examine repair of DNA damage induced by many carcinogens and anti-cancer
agents.
Conclusion: This methodology provides a sensitive assay for studying nucleotide excision repair in vivo.
Significance: Repair of a broad range of DNA lesions can be readily observed in vivo.
DNA damage by UV and UV-mimetic agents elicits a set of
inter-related responses in mammalian cells, including DNA
repair, DNA damage checkpoints, and apoptosis. Convention-
ally, these responses are analyzed separately using different
methodologies. Here we describe a unified approach that is
capable of quantifying all three responses in parallel using
lysates from the same population of cells. We show that a highly
sensitive in vivo excision repair assay is capable of detecting
nucleotide excision repair of a wide spectrum of DNA lesions
(UV damage, chemical carcinogens, and chemotherapeutic
drugs) within minutes of damage induction. This method there-
fore allows for a real-time measure of nucleotide excision repair
activity that can be monitored in conjunction with other com-
ponents of the DNA damage response, including DNA damage
checkpoint and apoptotic signaling. This approach therefore
provides a convenient and reliable platform for simultaneously
examining multiple aspects of the DNA damage response in a
single population of cells that can be applied for a diverse array
of carcinogenic and chemotherapeutic agents.
DNA damage is repaired by many enzyme systems that pro-
mote survival and activate cellular signaling pathways in mam-
malian cells including DNA damage checkpoints, which arrest
cell cycle progression and apoptosis that dismantles cellular
architecture (1). Commonly, these three phenomena (repair,
checkpoint, and apoptosis) are analyzed separately, though it is
known that the three responses interface and share some mech-
anistic features (1–3). Therefore, there is a need to analyze the
three responses simultaneously for a deeper understanding of
cellular response to DNA damage within the same spatio-tem-
poral framework.
Ultraviolet (UV) light-induced DNA photoproducts are
removed from the human genome by the nucleotide excision
repair system (4 – 6). Recently, we developed a method for
quantifying the repair of UV-induced DNA damage in vivo with
high sensitivity, which can detect repair within minutes of UV
irradiation (7, 8). The method consists of observing the nucle-
otide excision repair-specific 30-nt-long oligomers (“nominal
30-mers,” which are actually in the range of 24 –32 nucleotides)
that had previously only been visualized in vitro (9 –12). The
method involves cell lysis followed by immunoprecipitation of
the nominal 30-mer with antibodies against the repair factor
TFIIH which is bound to the oligomer or with antibodies
against cyclobutane pyrimidine dimers (CPDs)4 or (6 – 4) pho-
toproducts [(6 – 4)PPs] and labeling of the excised oligonucle-
otide with either radioisotope or non-radioisotopic methods (7,
8, 13). The approach in its original form has been quite useful
for characterizing DNA repair in mammalian cells in vivo (7, 8,
13) and also for mapping excision repair events genome-wide
(14) but has so far only been used for studying repair of UV-
induced DNA damage. Because nucleotide excision repair
operates on essentially all types of DNA lesions, in particular on
the so-called “bulky DNA adducts” (4, 5), we suggested that
with appropriate modifications the method could also be used
for investigating other DNA damage repaired by nucleotide
excision repair as well.
In this report we describe an improvement of the in vivo
excision assay for nucleotide excision repair that does not
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repair factors or DNA lesions. This modified assay has enabled
us to monitor the repair of, in addition to UV photoproducts,
the damage induced by carcinogenic chemicals benzo[a]pyr-
ene-7,8-dihydrodiol-9,10-epoxide (BPDE), N-acetoxy-2-acetyl-
aminofluorene (AAF), and formaldehyde as well as the antican-
cer agent cisplatin. Moreover, in this approach the sensitivity
and simplicity of the system has also enabled us to analyze
checkpoint and apoptosis simultaneously with repair and using
the same cell extract made from only a small number of cells.
This integrated approach should be useful for mechanistic
studies on DNA repair, checkpoint, and apoptosis in a con-
certed manner and in a type of damage-independent fashion.
Materials and Methods
Cell Lines and Cell Culture—HeLa cells were obtained from
the Korean Cell Line Bank of Seoul National University (Seoul,
Korea). The Chinese hamster ovarian (CHO) cell lines AA8
(wild-type) and its derivative UV135 (XPG-deficient), the hu-
man melanoma cell line A375, and the human fibroblast cell
line GM00200 were purchased from the American Type Cul-
ture Collection (Rockville, MD). All cell lines were cultured in
Dulbecco’s modified Eagle’s medium (Gibco) supplemented
with 10% fetal bovine serum at 37 °C in a 5% CO2 humidified
incubator. Cisplatin was obtained from Sigma. BPDE and AAF
were obtained from the NCI Chemical Carcinogen Reference
Standard Repository (Midwest Research Institute, MO). Bleo-
mycin and mitomycin C (MMC) were purchased from Santa
Cruz Biotechnology and Abcam (Cambridge, MA), respec-
tively. All other chemicals were purchased from Sigma.
Genotoxin Exposure—For UV exposures, cells that were
grown to near confluency in 100 mm or 150 mm diameter
plates were washed with phosphate-buffered saline (PBS,
Gibco) and then exposed to the indicated influence of UV radi-
ation using a germicidal lamp that emits primarily 254 nm light.
For formaldehyde or MMC treatments, the culture medium
was replaced with serum-free medium prior to treatment. For
treatments with the other DNA-damaging agents (BPDE, AAF,
cisplatin, and bleomycin), the indicated doses of each chemical
compound were added directly to the culture medium.
Cell Lysis and in Vivo Excision Assay—At the indicated time
points, cells were washed with ice-cold PBS and harvested with
a cell scraper. Cells were pelleted by centrifugation, resus-
pended in a 10 packed cell volume of a Triton X-100 lysis
buffer (20 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1 mM EDTA, 1
mM EGTA, and 1% Triton X-100), and incubated on a rotating
mixer for 15 min at 4 °C. Soluble lysates were then obtained by
centrifugation at 20,000  g for 1 h and transferred to new
tubes. Small portions (10 –20%) of the lysates were saved for
immunoblot analysis. The insoluble pellets were subjected to
isolation of genomic DNA for immunoslot blot assays (de-
scribed below). The soluble cell lysates were incubated with
RNase A (5–10 g/ml) and RNase T1 (5–10 units/ml) for 20
min at 37 °C and then treated with 0.15 mg/ml of proteinase K
for 30 min at 55 °C. The reactions were subsequently extracted
with phenol/chloroform precipitated in ethanol. After centri-
fugation, the pellets were washed with 70% ethanol, resus-
pended in TE buffer, and then subjected to labeling with termi-
nal deoxynucleotidyl transferase and the nucleotide analog
biotin-11-dUTP as described previously with a few modifica-
tions (7). Briefly, the extracted DNA was incubated with 20
units of terminal deoxynucleotidyl transferase (New England
Biolabs), 10 M of biotin-11-dUTP (Biotium, Inc.), and 0.25 mM
CoCl2 in 50 l of 1 Terminal Transferase Reaction Buffer
(New England Biolabs) for 30 min at 37 °C. The reactions were
stopped by addition of 10 mM EDTA, incubated with RNase A
(10 –20 g/ml)/RNase T1 (30 –50 units/ml) for 20 min at 37 °C,
and then treated with 0.4 mg/ml of proteinase K in the presence
of 0.4% SDS. The reactions were subsequently subjected to phe-
nol/chloroform extraction followed by ethanol precipitation.
The labeled DNAs were loaded onto 12% TBE-urea gels and run
in 1 TBE at 150 V. Following gel electrophoresis, the DNAs
were transferred onto a modified nylon membrane (Zeta-Probe
membranes by Bio-Rad or Biodyne membrane by Pierce) in
0.5 TBE buffer at 300 mA for 1 h and then fixed to the mem-
brane by UV cross-linking. Detection of biotin-labeled DNA
was achieved with the Chemiluminescent Nucleic Acid
Detection Module (Thermo Scientific) using an ImageQuant
LAS 4000 Mini apparatus (GE Healthcare Life Sciences). The
relative intensities of the bands were analyzed by using
ImageQuant TL Software (GE Healthcare Life Sciences).
Immunoslot Blot Assay—The insoluble pellets obtained dur-
ing the preparation of cell lysates (described above) were resus-
pended in a 10 packed cell volume of PBS and then incubated
with 0.5 g/ml of RNase A for 2 min at room temperature.
Proteinase K was added to a final concentration of 0.25 g/ml.
Genomic DNA was then isolated using the QIAamp DNA Mini
kit (Qiagen) and then subjected to immuno-slot blot analysis as
described previously (15, 16). Briefly, purified genomic DNA
was denatured and then loaded onto a nitrocellulose mem-
brane. The membrane was baked and then probed with anti-
CPD (Kamiya Biomedical) or anti-(6 – 4)PP (Cosmo Bio) anti-
bodies. Following incubation with horseradish peroxidase
(HRP)-conjugated anti-mouse secondary antibody, chemilu-
minescent signals were detected with ECL reagent (GE Health-
care Life Sciences) using an ImageQuant LAS 4000 Mini appa-
ratus (GE Healthcare Life Sciences). The relative intensities of
the signals were quantified with ImageQuant TL Software (GE
Healthcare Life Sciences). To confirm equal loading of genomic
DNA, membranes were stained with SYBR Gold (Invitrogen).
Protein Immunoblotting—Soluble cell lysates were separated
by SDS-PAGE and transferred to Hybond ECL membranes (GE
Healthcare Life Sciences), probed with the indicated antibod-
ies, and detected with ECL reagent (GE Healthcare Life Sci-
ences) using an ImageQuant LAS 4000 Mini apparatus (GE
Healthcare Life Sciences). The antibodies were obtained from
commercial sources. Anti-p53 antibody was purchased from
Santa Cruz. All of the other antibodies were obtained from Cell
Signaling Technology.
Immunoprecipitation of Excised Oligomers—Detection of
excision products containing specific UV photoproducts was
done as previously described (7, 8). Briefly, 5 l of protein G
Dynabeads slurry (Invitrogen) and anti-rabbit Dynabeads
slurry (Invitrogen) were mixed, washed with Wash Buffer I (20
mM Tris-Cl, pH 8.0, 2 mM EDTA, 150 mM NaCl, 1% Triton
X-100, and 0.1% SDS), resuspended in 20 l of IP buffer (20 mM
Tris-Cl, pH 8.0, 2 mM EDTA, 150 mM NaCl, 1% Triton X-100,
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and 0.5% sodium deoxycholate) containing 1 l of rabbit anti-
mouse IgG (Abcam) and anti-CPD or anti-(6 – 4)PP antibody,
and incubated for 3 h at 4 °C. The isolated beads were incubated
with the purified DNA in 100 l of IP buffer overnight at 4 °C
and then subjected to sequential washes with Wash Buffer I,
Wash Buffer II (20 mM Tris-Cl, pH 8.0, 2 mM EDTA, 500 mM
NaCl, 1% Triton X-100, and 0.1% SDS), Wash Buffer III (10 mM
Tris-Cl pH 8.0, 1 mM EDTA, 150 mM LiCl, 1% Nonidet P-40,
and 1% sodium deoxycholate), Wash Buffer IV (100 mM Tris-Cl
pH 8.0, 1 mM EDTA, 500 mM LiCl, 1% Nonidet P-40, and 1%
sodium deoxycholate), and twice with TE buffer (10 mM Tris-Cl
pH 8.0, 1 mM EDTA). The oligonucleotides containing UV pho-
toproducts were eluted with 100 l of Elution Buffer (50 mM
NaHCO3, 1% SDS, and 20 g/ml of glycogen) at 65 °C for 15
min, followed by phenol/chloroform extraction and ethanol
precipitation. The isolated oligonucleotides were then 3-end
labeled with biotin and analyzed as described above.
Results and Discussion
Simple Method for Monitoring DNA Repair, Checkpoint, and
Apoptosis from a Single Cell Culture—We have previously
described a method for isolation and quantification of excised
oligonucleotides (nominal 30-mers) generated in vivo by nucle-
otide excision repair using a variety of cell lysis methods (7, 8,
13). We have expanded the utility of this assay by using a milder
FIGURE 1. An integrated approach for monitoring the repair of genomic
DNA damage, the generation of excised oligonucleotide repair prod-
ucts, and the activation of DNA damage signaling pathways in a single
culture of cells. Following the exposure of cells to DNA-damaging agents,
cells are lysed with a non-ionic detergent and soluble and insoluble fractions
separated by centrifugation. The insoluble pellet is subjected to extraction of
genomic DNA to measure the presence of lesions via immuno-slot blot assay.
The soluble cell lysate is processed for extraction and visualization of the
oligonucleotide products of excision repair or used in immunoblot assays for
monitoring DNA damage response signaling (checkpoint and apoptosis).
FIGURE 2. Analysis of genomic DNA, excised oligonucleotide repair products, and DNA damage checkpoint signaling in UV-irradiated cells. A, analysis
of excised oligomers released from genomic DNA following UV irradiation. HeLa cells were exposed to 10 J/m2 of UV (254 nm) light and harvested at the
indicated time points. Following cell lysis and centrifugation the soluble fractions of the cells were processed for isolation and labeling of excised oligonucle-
otide repair products. To measure the total excised oligomers, the purified small DNA molecules were directly labeled with biotin, separated by gel electro-
phoresis, transferred to a membrane, and then detected with HRP-conjugated streptavidin (left). For detection of excision products containing (6 – 4)PPs or
CPDs, the purified small DNA molecules were immunoprecipitated with anti-(6 – 4)PP (middle) or anti-CPD (right) antibodies prior to biotinylation. Data are
presented as the mean values  S.D. obtained from at least three independent experiments. B, immuno-slot blot assay for measuring the removal of
photoproducts from genomic DNA. Genomic DNA was isolated from the insoluble pellets in A and then used in immuno-slot blot assays with antibodies
against (6 – 4)PPs and CPDs. The Sybr-Gold staining shows equal loading of total genomic DNA. A quantitative analysis of immuno-slot blot assays in which the
signal at time zero was set to 100 is also shown. The average (and S.D.) level of photoproduct removal from three independent experiments is shown. C, analysis
of UV-induced DNA damage checkpoint signaling. A small portion of the soluble fractions prepared in A were analyzed by SDS-PAGE and immunoblotting with
the indicated antibodies.
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cell lysis method and by using both the soluble and insoluble
fractions to monitor repair, the checkpoint response, and
apoptosis.
A schematic of our approach is shown in Fig. 1. Cells are
exposed to UV (or another DNA-damaging agent) and follow-
ing incubation periods of various lengths cells are lysed in an
isotonic buffer containing a non-ionic detergent and then cen-
trifuged to separate the soluble nominal 30-mer excision prod-
ucts and soluble cellular proteins from the insoluble fraction
which contains chromatin and cellular organelles. Genomic
DNA is purified from this insoluble fraction and then probed by
immuno-slot blotting with DNA lesion-specific antibodies to
monitor the removal of damage from the genome.
The soluble fraction is used to monitor DNA repair and var-
ious DNA damaging signaling pathways, including DNA dam-
age checkpoints that delay cell cycle progression and apoptosis,
which induces cell death in damaged cells. DNA repair activity
is examined by detecting the excised, damage-containing oligo-
nucleotide products of nucleotide excision repair that are
released from genomic DNA during repair. The remaining sol-
uble lysate is probed for DNA damage checkpoint activation by
immunoblotting for phosphorylation of the DNA damage
checkpoint kinases Chk1 and Chk2 and for apoptosis by immu-
noblotting for proteolytic cleavage of caspase 3 and poly-ADP-
ribose polymerase (PARP).
An application of this method using UV-irradiated HeLa
cells is shown in Fig. 2. Cells were harvested and lysed at the
indicated time points following irradiation. Soluble and insolu-
ble fractions were then prepared and used to probe for nucleo-
tide excision repair. Fig. 2A shows repair as measured by the
chemiluminescence signal of biotin-labeled excision products
that were either probed directly or immunoprecipitated with
FIGURE 3. Detection of excised oligomers containing bulky base adducts in vivo. A, HeLa cells were treated with different concentrations of BPDE (0.01–10
M), harvested 1 h later, and then processed for analysis of excision products and DNA damage checkpoint signaling. For UV-induced excision products, cells
were exposed to 10 J/m2 of UV and harvested after 1 h of incubation. Immunoblotting was performed with antibodies against the indicated proteins (bottom).
B, CHO wild-type (CHO-WT) and XPG-deficient (CHO-XPG) cells were treated with different concentrations of BPDE (0.05, 0.1, 0.5, 1, 5 M) for 1 h and then
analyzed for excision and DNA damage checkpoint signaling. C, A375 cells were treated for 1 h with BPDE (0, 1.25, 2.5 M) and analyzed for excision repair. For
detection of UV-induced excision products, cells were exposed to 10 J/m2 of UV and then harvested 1 h later. D, normal human fibroblasts (GM00200 cells) were
treated for 1 h with BPDE (0, 0.25, 0.5, 1 M) and analyzed for excision. E, HeLa cells were treated with AAF (1–10 M) for 1 h and analyzed for excised
oligonucleotides. Lane 6 represents the excised oligonucleotides generated in HeLa cells exposed to 10 J/m2 of UV and then harvested 1 h later.
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either (6 – 4) photoproduct or CPD antibodies. Fig. 2B shows
the repair of the same photoproducts as measured by the
remaining damage in chromosomal DNA by immuno-slot blot
(15). Several points of interest are evident in this figure. First,
the post-labeling/chemiluminescence method is quite sensi-
tive, capable of detecting repair at the earliest time points ana-
lyzed (15 min) when repair as probed by slot-blot of the
genomic DNA fraction is inconclusive because while the
excised oligonucleotide assay measures repair with virtually
zero background the immuno-slot blot assay measures repair as
the difference between two large numbers (15) and it is not
capable of unambiguously detecting repair when only a small
fraction of the damage is repaired. This is in particular evident
in the case of CPD repair, which is virtually undetectable for up
to 4 h by slot blot assay (Fig. 2B). In contrast, the repair of CPD
is detectable at the earliest time point (15 min) by the excision
assay and follows an essentially linear kinetics afterward (Fig.
2A). Secondly, the (6 – 4)PP is excised at a much faster rate than
CPDs, in agreement with previous in vivo (17) and in vitro (18)
observations. During the first hour following UV irradiation,
the (6 – 4)PP repair increases linearly as measured by both post-
excision labeling/chemiluminescence assay and the slot blot
assay. After the 1-h time point the excised oligomer signal grad-
ually decreases because as we have previously reported the
excised oligomer is degraded to small oligonucleotides contain-
ing the photoproducts that are no longer detectable by the exci-
sion assay, which measures mostly the primary excision prod-
ucts of 24- to 32-nt in length and the primary degradation
products of 20-nt but not smaller fragments (7, 8, 13). Finally,
we note that the improvement we have made in the excision
assay has enabled us to detect the nominal 30-mer without
immunoprecipitation and the mild lysis procedure has reduced
the background at higher molecular weight region of the gel,
which arises from genomic contamination in the soluble
fraction.
Fig. 2C shows that the soluble fraction that was used to detect
the excision product can also be used to probe for checkpoint
response as measured by the rapid Chk1 (Checkpoint kinase 1)
and p53 phosphorylation followed by the slower Chk2 phos-
phorylation, which reflects activation of the DNA damage sen-
sor kinases ATR and ATM by stalled replication forks and dou-
ble-strand breaks, respectively (2, 19, 20). Finally, Fig. 2C also
shows that the soluble fraction can be used to probe for activa-
tion of apoptotic signaling, which is monitored by immunoblot-
ting with antibodies that recognize cleavage products of the
apoptotic protease caspase-3 and one of its major targets, PARP
(Poly-ADP-ribose polymerase). To recapitulate, gentle lysis of
UV irradiated cells followed by separation of the soluble frac-
tion can be used to analyze the three main cellular responses to
DNA damage: repair, checkpoint, and apoptosis.
Analysis of Cellular Response to Chemical Carcinogens—Our
assay for detecting the nominal 30-mer generated by nucleotide
excision repair has so far been used only for measuring repair of
UV-induced photoproducts (7, 8, 13). Because nucleotide exci-
sion repair operates on virtually all base lesions and in particu-
lar on bulky base adducts generated by numerous chemical car-
FIGURE 4. Time-course analysis of excision generation following BPDE treatment. A, HeLa cells were treated with 1 M of BPDE, harvested at the indicated
time points, and then processed for analysis of excised oligonucleotides. Immunoblotting was performed with antibodies against the indicated proteins
(bottom). B, quantitative analysis (average and standard deviation) of three independent experiments performed as described in A. The highest BPDE-excision
product signal was arbitrarily set to a value of 100 for normalization of the signals from other time points.
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cinogens (4 – 6), we wished to investigate whether the assay can
be used to measure repair of damage caused by those chemical
carcinogens as well. Thus, we analyzed the repair of damage
caused by two of the most commonly used experimental car-
cinogens, BPDE and AAF. Both of these carcinogens generate
bulky adducts on guanine residues that are repaired by nucleo-
tide excision repair (21–23). Fig. 3, A and B shows that excision
of damage induced by these carcinogens can be detected in a
dose-dependent manner in HeLa cells. Fig. 3A (middle panel)
shows a longer exposure of the BPDE excision gel which reveals
that the excised oligonucleotides were detectable with a dose as
low as 0.05 M of this carcinogen. Moreover, immunoblot anal-
ysis of the same lysates that were used for detecting the excised
BPDE oligonucleotides showed that Chk1 was similarly phos-
phorylated in a dose-dependent manner.
We investigated the general applicability of the method to
mammalian cell lines by additional excision assays. First, we
show that a WT-CHO cell line also generates the nominal
30-mer in a BPDE dose-dependent manner while the XPG
mutant CHO cell line fails to produce the excision products
(Fig. 3C) consistent with the specificity of the assay. Secondly,
all commonly used human cell lines tested similarly generate
the nominal 30-mer upon treatment with this carcinogen. Fig.
3, D and E show that the excision repair-specific oligomers were
readily observed in BPDE-treated human melanoma (Fig. 3D)
and fibroblast (Fig. 3E) cell lines.
Kinetics of Formation and Degradation of the Excised Oli-
gonucleotide—Previously, we found that the primary excision
products (nominal 30-mer) of UV-induced photoproducts
were degraded to smaller oligonucleotides of 20 nt with a
half-life of about 1 h (8). We wished to determine if this also
occurred with DNA damage induced by chemical carcinogens.
Hence, we followed the time course of the appearance and dis-
appearance of BPDE excision products. Fig. 4A shows that the
level of BPDE nominal 30-mers reaches a maximum intensity at
1 h following treatment and then goes down with a half-life of
1 h. For comparison, in Fig. 1B we show the kinetics of for-
mation and decay of (6 – 4) photoproduct nominal 30-mer that
FIGURE 5. Examination of excision repair products induced by cisplatin. A, HeLa cells were treated for 4 h with cisplatin (0.1, 0.3, 0.6, 0.9 mM) and then
analyzed for excision repair. Lane 1 shows the excised oligonucleotides that were generated in HeLa cells following exposure to 5 J/m2 of UV and then
harvested after 30 min incubation. Immunoblotting was performed with antibodies against the indicated proteins (bottom). B, quantitative analysis
(average and standard deviation) of three independent experiments as shown in A. C, human melanoma cells (A375) were treated with different
concentrations of cisplatin, harvested 4 h later, and then analyzed for excision products. D, CHO wild-type (CHO-WT) and XPG-deficient (CHO-XPG) cells
were treated with different concentrations of cisplatin (0.1, 0.3, 0.6, 0.9 mM), harvested 4 h later, and then processed for analysis of excision repair. Small
portions of cell lysates were analyzed by immunoblotting with antibodies against the indicated proteins (bottom). E, HeLa cells were treated with
cisplatin (0.6 mM), harvested at the indicated time points, and then analyzed for excision products. Small portions of cell lysates were analyzed by
immunoblotting with antibodies against the indicated proteins (bottom). F, quantitative analysis (average and standard deviation) of three indepen-
dent assays as shown in E.
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was determined in a previous study (7, 8). As is apparent, the
kinetics of formation and degradation of nominal 30-mers car-
rying BPDE or (6 – 4) photoproducts are very similar, indicating
that the BPDE-guanine adduct is repaired as efficiently as the
(6 – 4) photoproduct. Interestingly, analyses of checkpoint/apo-
ptosis response of BPDE treated cells (Fig. 4A, bottom panel)
reveal Chk1 phosphorylation is an early response to DNA dam-
age, consistent with the notion that the ATR-Chk1 axis is acti-
vated by ssDNA signal generated by stalled replication forks or
by nucleotide excision repair gaps (19, 24) whereas Chk2 phos-
phorylation represents activation of the ATM-Chk2 axis by
double-strand breaks which appear at slower kinetics as a con-
sequence of replication fork collapse or apoptosis-initiated
chromatin fragmentation (2, 25). Indeed, in contrast to the
rapid Chk1 phosphorylation, Chk2 phosphorylation appears to
exhibit kinetics similar to that of PARP cleavage (Fig. 4A,
bottom).
Simultaneous Analysis of Repair, Checkpoint, and Apoptosis
in Response to Anti-cancer Drugs—The majority of chemother-
apeutic drugs kill cancer cells by damaging DNA and hence it is
of importance to be able to analyze cellular responses to DNA
damage by simultaneously analyzing for repair, checkpoint, and
apoptosis. We carried out such analyses with the three most
commonly used anti-cancer drugs, cisplatin, mitomycin C, and
bleomycin.
Cisplatin introduces DNA damage in the form of Pt-GpG,
Pt-ApG, and Pt-GpXpG intrastrand and G-Pt-G interstrand
crosslinks (26). In vitro studies have demonstrated that intras-
trand crosslinks induced by cisplatin are removed from DNA in
the form of short oligomers by the nucleotide excision repair
system (26 –30). We therefore applied our combined DNA
damage response assay to cisplatin treated cells. Fig. 5, A and B
shows that the nominal 30-mer of nucleotide excision repair is
generated by cisplatin in a dose-dependent manner and in par-
allel with excision repair, checkpoint activation, and apoptosis
can be detected by immunoblotting for Chk1 and Chk2 phos-
phorylation and PARP cleavage, respectively (Fig. 5A, bottom
panel). As in the case of BPDE damage, cisplatin damage exci-
sion is also detectable in other mammalian cell lines including
human fibroblasts (Fig. 5C) and WT-CHO but not XPG
mutant-CHO cells (Fig. 5D), as would be expected from the
specificity of the in vivo excision assay. Interestingly, when the
formation and degradation kinetics of cisplatin oligomer exci-
sion products were analyzed (Fig. 5, E and F) they exhibited
CPD excision product-like behavior (7, 8) in contrast to BPDE
oligomers, which demonstrated (6 – 4) photoproduct-like
behavior (see Fig. 4). The cisplatin adducts are removed at a
slow rate and as a consequence the primary excision products
are detectable for up to 6 h after which degradation dominates
and the total detectable excised oligomers decay, as was
observed with CPDs in previous studies (7, 8, 13). Finally, we
note that even though cisplatin makes G-Pt-G interstrand
crosslinks (26), our post-excision labeling assay does not detect
products that could be assigned to interstrand crosslink repair.
Mitomycin C is another drug that makes both intrastrand
and interstrand lesions by attacking the N2 position of guanine
(31, 32). Fig. 6A shows that mitomycin adducts are removed
from DNA by the canonical dual incision. As in the case of
cisplatin interstrand crosslinks there is no evidence of mitomy-
cin C interstrand crosslink repair by our post-excision labeling
assay. Treatment of cells with bleomycin, which introduces
breaks in DNA but does not form stable base adducts (33, 34),
did not generate the nominal 30-mer diagnostic of nucleotide
excision repair but caused large scale DNA fragmentation (Fig.
FIGURE 6. Detection of excised oligonucleotides following treatment with the anti-cancer compounds mitomycin C (MMC) and bleomycin. A, HeLa cells
were treated with the indicated concentrations of mitomycin C (1, 10, 30, 100 M), harvested after 1 h incubation, and then analyzed for the generation of
excised oligonucleotides. Immunoblotting was performed with antibodies against the indicated proteins (bottom). B, HeLa cells were treated with bleomycin
(0.7, 3, 17, 83 M) for 1 h and then processed for detection of excised oligonucleotides. Lane 7 in A and B show excision repair products generated within 1 h after
the exposure HeLa cells to 5 J/m2 of UV. Immunoblotting was performed with antibodies against the indicated proteins (bottom).
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6B). Consistent with the general notion that UV-mimetic
agents primarily activate the ATR-Chk1 axis and secondarily
the ATM-Chk2 pathway and the reverse order for radiomi-
metic agents (1, 19, 20, 25), we observe a strong and relatively
rapid Chk1 phosphorylation by mitomycin treatment and con-
versely strong Chk2 phosphorylation at relatively low dose of
bleomycin and only a weak signal of Chk1 phosphorylation at
higher doses of the drug (Fig. 6, A and B, lower panels).
Analysis of Formaldehyde Induced DNA Damage Response—
Many industrial, household, and medicinal products contain
formaldehyde-based polymers from which the highly reactive
monomeric form is released in sufficient quantities which
reacts with cellular constituents to produce a variety of
lesions (35). The most prominent among these are DNA base
adducts, DNA-protein crosslinks, and protein-protein cross-
links. Though there is genetic evidence supporting a role for the
nucleotide excision repair system in promoting resistance to
formaldehyde (36, 37), the DNA lesions targeted by nucleotide
excision repair are not known and several studies have reported
that protein-DNA crosslinks are repaired at similar rates in
normal and excision repair-deficient formaldehyde-treated
human cells (38 – 40). We therefore used our assay to investi-
gate the role of nucleotide excision repair of formaldehyde
damage as well as the DNA damage response elicited by form-
aldehyde. Fig. 7 shows the results of our assay for simultaneous
detection of repair, checkpoint, and apoptosis induced by form-
aldehyde. As seen in Fig. 7A, the nominal 30-mer representing
excision of DNA adducts is observed over a narrow dose range
and at higher doses the signal disappears (Fig. 7, A and B) pre-
sumably because of the extensive DNA-protein and protein-
protein crosslinking that traps the excision product in the insol-
uble fraction. In contrast to excision, checkpoint activation as
measured by Chk1 and Chk2 phosphorylation and PARP cleav-
age is observed at higher concentrations of formaldehyde and
diminishes as a result of extensive crosslinking at only the high-
est concentration used. Of significance, the nominal 30-mer
was similarly observed with other human cell lines treated with
formaldehyde (Fig. 7, C and D) consistent with the general util-
ity of the method. Time course analyses of repair in formalde-
hyde-treated cells showed only a small time window for damage
FIGURE 7. Detection of excision repair products following treatment with formaldehyde. A, HeLa cells were treated with various concentrations of
formaldehyde (0.1, 0.2, 0.4, 0.6, 0.8, 1 mM), harvested after 3 h incubation, and then analyzed for the generation of excision products. Immunoblotting was
performed with antibodies against the indicated proteins (bottom). B, quantitative analysis (average and standard deviation) of three independent experi-
ments as shown in A. C, detection of excised oligonucleotides in A375 cells treated for 3 h with formaldehyde at different concentrations (0.2, 0.4, 0.6, 0.8 mM).
Lane 1 shows the generation of repair products 1 h after exposure of HeLa cells to 5 J/m2 of UV. D, GM00200 cells were treated at different concentrations (0.2,
0.4, 0.6, 0.8 mM), harvested 3 h later, and analyzed for excised oligomers. E, HeLa cells were treated with formaldehyde (0.4 mM), harvested at the indicated time
points, and then analyzed for excision repair products. Lane 8 shows the excised oligonucleotides induced 1 h following exposure to 5 J/m2 of UV. F,
quantitative analysis (average and standard deviation) of three independent experiments as shown in E.
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removal (Fig. 7, E and F). We note however that even though
formaldehyde causes extensive DNA-protein crosslinks, our
assay is incapable of detecting the repair of these damages. In
fact, it has been shown that human excision repair is capable of
only excising small peptide-DNA crosslinks but not those of
proteins in the range of 10 kDa (37, 41, 42). This limitation
notwithstanding, we believe that our assay would be useful in
studying the formation and repair of many DNA damaging
agents including other carcinogens and chemotherapeutic
drugs.
Conclusions
In this study, we describe a simple method for examining the
three main cellular responses to DNA damage by carcinogens
and chemotherapeutic drugs that form base adducts: nucleo-
tide excision repair, DNA damage checkpoints, and apoptosis.
Excision repair is probed by detection of the nucleotide exci-
sion repair specific 24 –32 nt-long oligomers (“nominal 30-
mer”) by post-excision biotin tagging and chemiluminescence.
Checkpoint and apoptosis are examined by immunoblotting for
Chk1 and Chk2 phosphorylation and for PARP cleavage,
respectively. The method has certain advantages for probing
for these endpoints over existing methods. First, the in vivo
excision repair assay probes for the production of unique size
oligonucleotides that are generated by the nucleotide excision
repair system in response to DNA damage. The production of
these oligomers occurs over a background of virtually zero and
is capable of measuring repair of as little as 0.1% of UV damage.
In contrast, slot blot (15) or ELISA (43) assays measure the
decrease of damage-specific signal intensity in terms of a differ-
ence between two large numbers and as a consequence are
much less sensitive than the in vivo excision assay. Secondly,
both slot blot and ELISA require damage-specific antibodies
whereas the excision assay does not and hence can be used for
all damages that are processed by nucleotide excision repair
with extreme sensitivity. Finally, the simplified method we
describe for preparing cell lysates is compatible for detecting
repair by chemiluminescence and checkpoint and apoptosis by
immunoblotting using the same soluble fraction of the cell
lysate from as few as 5  105 cells. The assay is thus suitable for
screening for these phenomena of genotoxic responses in clin-
ical or epidemiological settings and for assessing the temporal
order of these three critical cellular responses to DNA damage
using the same experimental platform.
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